Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
NSE India S.E.
18:51:03 08/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1,632.60 INR | +2.05% |
|
+4.45% | -9.83% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 200,521 | 168,871 | 187,216 | - | - |
| Change | - | -15.78% | 10.86% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 196,072 | 188,380 | 187,216 |
| Change | - | -9.93% | 8.56% | -3.92% | -0.62% |
| P/E | -1,075x | -229x | 37x | 21.5x | 21x |
| PBR | - | - | 3.01x | 2.63x | 2.56x |
| PEG | - | -1x | -0x | 0.3x | 9.54x |
| Capitalization / Revenue | - | 11.9x | 7.9x | 5.45x | 4.96x |
| EV / Revenue | - | 12.7x | 8.28x | 5.49x | 4.96x |
| EV / EBITDA | - | 59.4x | 24.5x | 13.7x | 12.9x |
| EV / EBIT | - | 719x | 39.2x | 18x | 20.7x |
| EV / FCF | - | -32.2x | 37.3x | 24x | 22.8x |
| FCF Yield | - | -3.1% | 2.68% | 4.16% | 4.4% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 44.15 | 76.08 | 77.75 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 14,216 | 23,689 | 34,336 | 37,754 |
| EBITDA 1 | - | 3,042 | 8,006 | 13,782 | 14,510 |
| EBIT 1 | - | 251.3 | 5,008 | 10,440 | 9,043 |
| Net income 1 | -179.7 | -738 | 4,602 | 8,994 | 8,912 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 | - |
| Reference price 2 | 1,752.25 | 1,473.30 | 1,632.60 | 1,632.60 | 1,632.60 |
| Nbr of stocks (in thousands) | 114,436 | 114,621 | 114,674 | - | - |
| Announcement Date | 5/5/25 | 13/5/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.24x | 8.12x | 24.02x | - | 1.95B | |
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | |
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | |
| 48.64x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 42.3x | 8.09x | 26.47x | -.--% | 33.29B | |
| -69.1x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 19.29x | 13.31x | 8.99x | 0.33% | 40.87B | |
| Weighted average by Cap. | 21.96x | 12.99x | 11.86x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
